José A Muñoz-Moreno

Dados Biográficos

ID7733992
NOMEJosé A Muñoz-Moreno
PRENOMESJosé A
SOBRENOMEMuñoz-Moreno
ASSINATURAMUÑOZ-MORENO J A
AFILIAÇÕESUniversitat Autonòma de Barcelona
ORCID0000-0002-7239-5422
VERIFICADOSim
TOTAL DE OBRAS6
TOTAL DE CITAÇÕES0
TOTAL COMO AUTOR6
TOTAL COMO EDITOR0
PRIMEIRO ANO DE PUBLICAÇÃO2007
ANO MAIS RECENTE DE PUBLICAÇÃO2022
ÍNDICE H0

  • Accentuated aging associated with HIV in a Mediterranean setting occurs mainly in persons aged>70 years

    Eugènia Negredo, Cora Loste et al.ARTICLEAIDS Care2022

    In an ongoing Mediterranean cohort, we compared age-related conditions between 208 HIV-infected persons and 104 matched controls. ≥3 comorbidities were found in 31.0% of HIV-infected patients and 8.7% of controls. Conditions significantly more frequent among the HIV-infected population were: lipid abnormalities, cancer, osteopenia/osteoporosis, liver disease, sexual dysfunction, hearing deficit, sleep disorders, falls, cognitive complaints, being…

  • Resilience, ageing, and quality of life in long-term diagnosed HIV-infected patients

    Carmina R Fumaz, Aintzane Ayestaran et al.ARTICLEAIDS Care2015

    Resilience is a predictor of emotional well-being and psychological adjustment in people living with HIV infection. We report the results of a cross-sectional study in which we evaluated resilience and its association with perception of ageing, coping strategies, quality of life, and emotional status in a group of long-term diagnosed HIV-infected patients. The analysis included 151 consecutive participants (57.6% men). Resilience was moderately h…

  • Screening for neurocognitive impairment, depression, and anxiety in HIV-infected patients in Western Europe and Canada

    Kevin Robertson, Carmen Bayón et al.ARTICLEAIDS Care2014

    CRANIum, a cross-sectional epidemiology study in Western Europe and Canada, was conducted to describe and compare the prevalence of a positive screen for neurocognitive impairment (NCI), depressive symptoms, and anxiety in an HIV-positive population either receiving combination antiretroviral therapy (cART) or who were naive to antiretroviral therapy (ART). HIV-positive patients ≥18 years of age attending a routine medical follow-up visit and abl…

  • Effectiveness of Mindfulness-Based Cognitive Therapy on the Quality of Life, Emotional Status, and CD4 Cell Count of Patients Aging with HIV Infection

    Open AccessMarian González-García, María José Ferrer et al.ARTICLEAIDS and Behavior2013

  • Sustained antiretroviral treatment adherence in survivors of the pre-Haart era

    C R Fumaz, José A Muñoz-Moreno et al.ARTICLEAIDS Care2008

    The objective of this study was to assess adherence of HIV-1-infected patients who started treatment in the pre-HAART era and to determine variables associated with better adherence, including relevant attitudes and beliefs. This is a cross-sectional study enrolling patients who had received antiretroviral therapy for >or=10 years. Adherence was evaluated through self-reporting and plasma drug concentrations. Treatment variables, attitudes and be…

  • Influence of the type of pegylated interferon on the onset of depressive and neuropsychiatric symptoms in HIV-HCV coinfected patients

    Carmina R Fumaz, José A Muñoz-Moreno et al.ARTICLEAIDS Care2007

    This is a prospective observational comparative 48-week study to assess the impact of the different types of Peg-IFN on depressive and neuropsychiatric symptoms during treatment in HIV-HCV coinfected patients. Thirty-one patients treated with Peg-IFN alpha-2b 1.5 microg/kg/w plus ribavirine (RBV) (Peg-IFN alpha-2b Group) and 32 patients receiving Peg-IFN alpha-2a 180 microg/w plus RBV (Peg-IFN alpha-2a Group) were included. Depressive and neurops…